Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_assertion type Assertion NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_head.
- NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_assertion description "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_provenance.
- NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_assertion evidence source_evidence_literature NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_provenance.
- NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_assertion SIO_000772 18079016 NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_provenance.
- NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_assertion wasDerivedFrom befree-20140225 NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_provenance.
- NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_assertion wasGeneratedBy ECO_0000203 NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_provenance.